Co-delivery of imatinib and anti-STAT3 siRNA (non-invasive topical iontophoretic administration) using gold NPs is related to a remarkable decrease in tumor volume and tumor weight in melanoma tumor bearing mice, showing the efficacy of gold NPs in treatment of melanoma by inhibition of STAT3 [212]. Here, STAT3 is linked to neoplasm.